NewGenIvf Group Ltd (NASDAQ: NIVF)

Sector: Healthcare Industry: Medical Care Facilities CIK: 0001981662
Market Cap 128.79
P/B 0.00
P/E 0.00
P/S 0.00
ROIC (Qtr) 0.00
Div Yield % 0.00
Rev 1y % (Qtr) -12.94
Total Debt (Qtr) 5.50 Mn
Debt/Equity (Qtr) 0.19

About

NewGenIvf Group Ltd (NIVF) operates in the healthcare industry, specifically in the field of fertility services. The company's primary focus is on providing in-vitro fertilization (IVF) treatment services and surrogacy and ancillary caring services. NewGenIvf Group Ltd has a strong presence in the Asia Pacific region, with clinics in Thailand, Cambodia, and Kyrgyzstan. NewGenIvf Group Ltd generates revenue mainly from its IVF treatment services, which include traditional IVF and egg donation. These services are provided to individuals and couples...

Read more

Price action

Investment thesis

Bull case

  • Tangible assets of 11.32M provide exceptional 167.89x coverage of deferred revenue 67401, showing strong service capability backing.
  • Tangible assets of 11.32M provide robust 21.86x coverage of other current liabilities 517742, indicating strong asset backing.
  • Retained earnings of 16.56M provide full 3.19x coverage of long-term debt 5.20M, indicating strong internal capital position.
  • Retained earnings of 16.56M provide strong 31.99x coverage of other current liabilities 517742, indicating earnings quality.
  • Retained earnings of 16.56M represent substantial 0.56x of equity 29.38M, indicating strong internal capital generation.

Bear case

  • High receivables of 1.55M relative to inventory of 86977 (17.80 ratio) suggests aggressive credit terms or collection difficulties, potentially masking revenue quality issues.
  • Operating cash flow of 0 provides insufficient coverage of deferred revenue obligations of 67401, which is 0x, raising concerns about future service delivery capabilities.
  • Retained earnings of 16.56M provide limited buffer against comprehensive income items of (249711), which is -66.33x, indicating elevated exposure to market risks.
  • Cash position of 295289 provides weak coverage of payables of 797718, which is 0.37x, indicating potential working capital stress and supplier relationship risks.
  • Intangible assets of 24.24M represent a concerning 0.83x of shareholder equity 29.38M, indicating high exposure to potential impairment risks.

Peer comparison

Companies in the Medical Care Facilities
S.No. Ticker Company Market Cap P/E P/S Total Debt (Qtr)
1 HCA HCA Healthcare, Inc. 114.88 Bn 18.11 1.54 46.35 Bn
2 THC Tenet Healthcare Corp 18.07 Bn 13.34 0.87 13.19 Bn
3 UHS Universal Health Services Inc 14.64 Bn 10.65 0.86 5.11 Bn
4 FMS Fresenius Medical Care AG 14.10 Bn 16.69 0.61 14.98 Bn
5 EHC Encompass Health Corp 12.55 Bn 19.95 2.17 2.66 Bn
6 ENSG Ensign Group, Inc 10.08 Bn 30.72 2.09 2.16 Bn
7 DVA Davita Inc. 8.90 Bn 11.53 0.67 12.78 Bn
8 CHE Chemed Corp 6.38 Bn 22.87 2.52 0.14 Bn

Industry comparisons

Current Valuation Value Ind Avg Percentile
EV to Assets EV to Assets 0.01 1.26
EV to Cash from Ops. EV/CFO -0.03 12.78
EV to Debt EV to Debt 0.05 12.10
EV to EBIT EV/EBIT -1.20 10.74
EV to EBITDA EV/EBITDA -0.29 16.04
EV to Free Cash Flow [EV/FCF] EV/FCF -0.03 18.02
EV to Market Cap EV to Market Cap 2,136.67 432.64
EV to Revenue EV/Rev 0.05 2.77
Price to Book Value [P/B] P/B 0.00 -1.92
Price to Earnings [P/E] P/E 0.00 5.13
Dividend Metrics Value Ind Avg Percentile
Dividend Coverage Ratio Dividend Coverage Ratio 0.00 0.10
Dividend Payout Ratio % Div Payout % (Qtr) 0.00 -13.44
Dividend per Basic Share Div per Share (Qtr) 0.00 0.27
FCF Dividend Payout Ratio % FCF Div Payout % (Qtr) 0.00 5.42
Interest Coverage Int. cover (Qtr) 0.00 -97.94
Growth Metrics Value Ind Avg Percentile
Capex Growth (1y) % Capex 1y % (Qtr) 0.00 -114.65
Cash and Equivalents Growth (1y) % Cash & Equiv 1y % (Qtr) 0.00 65.22
Dividend Growth (1y) % Dividend Growth (1y) % 0.00 0.97
EBIAT Growth (1y) % EBIAT 1y % (Qtr) 0.00 -46.98
EBITDA Growth (1y) % EBITDA 1y % (Qtr) 0.00 75.97
EBIT Growth (1y) % EBIT 1y % (Qtr) 0.00 -61.19
EBT Growth (1y) % EBT 1y % (Qtr) 0.00 -115.48
EPS Growth (1y) % EPS 1y % (Qtr) 0.00 -24.32
FCF Growth (1y) % FCF 1y % (Qtr) 0.00 309.51
Gross Profit Growth (1y) % Gross Profit 1y % (Qtr) 0.00 17.88
Liquidity Ratios Value Ind Avg Percentile
Asset Utilization Ratio Asset Util Ratio (Qtr) 0.00 1.04
Cash Payout Ratio Cash Payout (Qtr) 0.00 0.04
Cash Ratio Cash Ratio (Qtr) 0.18 0.39
Current Ratio Curr Ratio (Qtr) 3.43 1.39
Debt to Equity Ratio Debt/Equity (Qtr) 0.19 -13.19
Interest Cover Ratio Int Coverage (Qtr) 0.00 -97.94
Times Interest Earned Times Interest Earned (Qtr) 0.00 -97.94
Profitability Value Ind Avg Percentile
EBITDA Margin % EBITDA Margin % (Qtr) 0.00 -95.81
EBIT Margin % EBIT Margin % (Qtr) 0.00 -94.97
EBT Margin % EBT Margin % (Qtr) 0.00 -105.60
Gross Margin % Gross Margin % (Qtr) 0.00 23.31
Net Profit Margin % Net Margin % (Qtr) 0.00 -106.14